Insider Trends: Exelixis Insider Receives Stock Award Uses Portion to Pay Taxes, Easing 90-Day Buy Trend
10:52 PM EST, 02/05/2021 (MT Newswires) -- Jeffrey Hessekiel, EVP & General Counsel, awarded 64,409 shares in Exelixis (EXEL) and sold 15,365 shares concurrently to meet tax obligations on Feb 03, 2021. After accounting for tax obligations this transaction resulted in a net acquisition of 49,044 company shares. Hessekiel, subsequent to the transactions detailed in the SEC Form 4 filing, controls 591,797 shares of company stock of which 590,798 shares are held directly and 999 shares are owned indirectly. The market value of the direct and indirect holdings, based on the prior-day closing price, is approximately $13.6 million.
In the 90 days prior to the date of this filing, there have been 27 insider transactions reported to the SEC for Exelixis. These transactions came from the activities of 8 individual insiders that resulted in a net acquisition of 192,529 company shares. This compares with the preceding 90-day window of time where there were 28 transactions from 8 insiders which resulted in the net acquisition of 279,727 shares.
This is less than the average level of insider transactions in the 324-company Bio Therapeutic Drugs peer group over the last 90-day period. Activity in the peer group averaged 56.3 transactions per company, with company insiders acquiring on average 24,493 shares.
SEC Story Link http://www.sec.gov/Archives/edgar/data/939767/000093976721000011/xslF345X03/wf-form4_161257780457140.xml
This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.